Jianhao Chen
Xiamen Key Laboratory Of Radiopharmaceuticals
Xiamen, 361003, China
Xiamen, 361003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineation.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 20, 2025
68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2025
FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy.
Journal: Journal for immunotherapy of cancer
Published: November 28, 2024
68Ga-MY6349 PET/CT imaging to assess Trop2 expression in multiple types of cancer.
Journal: The Journal of clinical investigation
Published: July 31, 2024
Enhanced Detection of Early Pulmonary Fibrosis Disease Using 68Ga-FAPI-LM3 PET.
Journal: Molecular pharmaceutics
Published: June 20, 2024
Development of [177Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 06, 2024
Utilizing sc-linker to integrate single-cell RNA sequencing and human genetics to identify cell types and driver genes associated with non-small cell lung cancer.
Journal: BMC cancer
Published: February 05, 2024
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade.
Journal: Signal transduction and targeted therapy
Published: October 28, 2023
Design, Preclinical Evaluation, and Clinical Translation of 68Ga-FAPI-LM3, a Heterobivalent Molecule for PET Imaging of Nasopharyngeal Carcinoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 14, 2023
Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 15, 2023
Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
Journal: Molecular pharmaceutics
Published: August 02, 2022
Prognostic value of fibroblast activation protein expressing tumor volume calculated from [68 Ga]Ga-FAPI PET/CT in patients with esophageal squamous cell carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 02, 2022
Last Updated: 09/26/2026